University Challenge Seed Fund (UCSF)

Take your research further with proof-of-concept funding that helps demonstrate commercial potential and move ideas towards real-world impact.

A close-up of three women and one man listening attentively to a pitch in an office.

What is the UCSF?

Oxford's University Challenge Seed Fund, managed by Oxford University Innovation (OUI), is the UK’s longest continuously running proof-of-concept fund - supporting early-stage projects with market potential.

If you’re a researcher at Oxford University, it could help you get the early validation you need to show that your idea could succeed.

25

years supporting Oxford University innovation

£18.5m

invested across 316 projects

108

spinouts created with UCSF support

£2.97bn

raised by UCSF-backed companies

Why apply?

Great research is only the first part of the journey. The next is to prove that your idea works in practice and has market value.

The UCSF is designed to support you with this, funding work such as:

generating proof-of-concept data

developing an early prototype

supporting pre-patent research

demonstrating usefulness to a market or audience

By supporting these early steps, we help you strengthen your case for taking your research further – whether that’s through licensing, company creation, or follow-on funding.

Apply for the UCSF Guidance notes

Who is it for?

The UCSF is open to University of Oxford researchers whose work shows market potential.

If your research could lead to new products, services or technologies that benefit society, the fund can help you take the next step towards realising your goals.

How much funding is available?

Awards typically range from £2,500 to £250,000, with calls opening quarterly in January, April, July and October.

A proven route from idea to impact

Over the past 25 years, the UCSF has supported companies that have gone on to achieve major success and global impact. These UCSF-backed companies were each sold in deals worth millions, demonstrating the long-term value that early proof-of-concept funding can help unlock.

OrganOx developed technology that keeps donor organs functioning outside the body for longer, helping improve transplant care. In 2025, the company announced a $1.5bn acquisition, demonstrating the long-term value that early-stage innovation can create.

Caristo Diagnostics uses AI to identify hidden heart attack risk from routine heart scans, helping clinicians detect problems earlier and personalise treatments to improve patient outcomes.

NaturalMotion developed Euphoria, a 3D animation technology used in video games. It was acquired by Zynga for $527 million in 2014.

YASA makes high-performance motors for electric vehicles. It was acquired by Mercedes-Benz for an undisclosed amount in 2021.

MiroBio focuses on therapeutics for inflammatory diseases. It was acquired by Gilead Sciences for $405m in 2022.

Designed to be sustainable, returns from successful companies are reinvested back into the fund, creating a long-term engine for innovation. Today, UCSF remains a vital part of how we help translate Oxford’s research into impactful technologies, companies, and solutions.

Supporting the next generation of innovation

When Oxford University companies succeed, the benefits extend beyond financial returns. Revenue from licensing, consultancy and company exits is shared with researchers, the departments, and the broader University.

This helps support future research, innovation and the creation of new companies – creating a cycle in which today’s successful ventures help fund the next generation of Oxford University breakthroughs.

Oxford University Innovation sign mounted on the exterior wall of the building

Ready to apply?

If you think your research may be a good fit for the UCSF, the best first step is to speak to an Oxford University Innovation expert.

If you haven’t yet started your journey with us, get in touch and we can connect you with the right person to discuss your idea and whether the fund is the right fit.

Start a conversation